QA: CAMBREX CORP in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2017_CAMBREX_CORP.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000820081')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000820081, CAMBREX CORP

  xvar xval
0 AssetsCurrent 322,655,000
1 IntangibleAssetsNetIncludingGoodwill 55,123,000
2 PropertyPlantAndEquipmentNet 217,092,000
3 remainder_Assets 16,995,000
4 LiabilitiesCurrent 95,462,000
5 LiabilitiesNoncurrent 21,946,000
6 remainder_Liabilities 89,030,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 60,422,000
9 ResearchAndDevelopmentExpense 14,292,000
10 remainder_Expenses 327,791,000
11 remainder_Revenues 490,644,000
12 remainder_NetIncome -6,461,000
13 remainder_ComprehensiveNetIncome -10,071,000
  yvar yval
0 Assets 611,865,000
1 Liabilities 206,438,000
2 Expenses 402,505,000
3 Revenues 490,644,000
4 StockholdersEquity 405,427,000
5 NetIncome 81,678,000
6 ComprehensiveNetIncome 76,642,500
7 BaseVar 863,992,000
8 EconomicCapitalRatio 1.89

Edgar->Model Mapping

Feature Distribution